These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 3106484

  • 1. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL, Rapp UR, Farrar WL.
    J Immunol; 1987 May 15; 138(10):3495-504. PubMed ID: 3106484
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA, Reinherz EL.
    J Immunol; 1987 Oct 01; 139(7):2143-8. PubMed ID: 2821108
    [Abstract] [Full Text] [Related]

  • 3. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, McKean DJ, Abraham RT.
    J Immunol; 1990 Mar 01; 144(5):1767-76. PubMed ID: 2407783
    [Abstract] [Full Text] [Related]

  • 4. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL, Jansen HW, Bister K, Fredrickson TN, Morse HC, Ihle JN, Rapp UR.
    J Cell Biochem; 1986 Mar 01; 30(3):195-218. PubMed ID: 3084503
    [Abstract] [Full Text] [Related]

  • 5. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
    Kumagai N, Benedict SH, Mills GB, Gelfand EW.
    J Immunol; 1987 Sep 01; 139(5):1393-9. PubMed ID: 3114365
    [Abstract] [Full Text] [Related]

  • 6. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF.
    Mol Reprod Dev; 1997 Jan 01; 46(1):11-8. PubMed ID: 8981358
    [Abstract] [Full Text] [Related]

  • 7. Cell cycle dependent growth factor regulation of gene expression.
    Morgan CJ, Pledger WJ.
    J Cell Physiol; 1989 Dec 01; 141(3):535-42. PubMed ID: 2512304
    [Abstract] [Full Text] [Related]

  • 8. IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T cells.
    Muñoz E, Zubiaga AM, Sims JE, Huber BT.
    J Immunol; 1991 Jan 01; 146(1):136-43. PubMed ID: 1845804
    [Abstract] [Full Text] [Related]

  • 9. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
    Reed JC, Alpers JD, Scherle PA, Hoover RG, Nowell PC, Prystowsky MB.
    Oncogene; 1987 May 01; 1(2):223-8. PubMed ID: 3501855
    [Abstract] [Full Text] [Related]

  • 10. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.
    Flores I, Jones DR, Ciprés A, Díaz-Flores E, Sanjuan MA, Mérida I.
    J Immunol; 1999 Jul 15; 163(2):708-14. PubMed ID: 10395661
    [Abstract] [Full Text] [Related]

  • 11. Signal transduction mediated by the reconstituted IL-2 receptor. Evidence for a cell type-specific function of IL-2 receptor beta-chain.
    Minami Y, Oishi I, Liu ZJ, Nakagawa S, Miyazaki T, Taniguchi T.
    J Immunol; 1994 Jun 15; 152(12):5680-90. PubMed ID: 8207200
    [Abstract] [Full Text] [Related]

  • 12. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
    Farrar WL, Evans SW, Rapp UR, Cleveland JL.
    J Immunol; 1987 Sep 15; 139(6):2075-80. PubMed ID: 3040863
    [Abstract] [Full Text] [Related]

  • 13. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ, Justement LB, Palmer E, Cambier JC.
    J Immunol; 1989 Aug 01; 143(3):1032-9. PubMed ID: 2787345
    [Abstract] [Full Text] [Related]

  • 14. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines.
    Tsuda H, Aso N, Sawada T, Hata H, Kawakita M, Mori KJ, Takatsuki K.
    Int J Cell Cloning; 1991 Mar 01; 9(2):123-33. PubMed ID: 2037810
    [Abstract] [Full Text] [Related]

  • 15. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE, Armelin MC.
    Oncogene; 1991 Jun 01; 6(6):1049-56. PubMed ID: 1648700
    [Abstract] [Full Text] [Related]

  • 16. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T, Okabe-Kado J, Hozumi M, Honma Y.
    Cancer Res; 1994 Jan 15; 54(2):592-7. PubMed ID: 8275499
    [Abstract] [Full Text] [Related]

  • 17. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
    Curran T, Bravo R, Müller R.
    Cancer Surv; 1985 Jan 15; 4(4):655-81. PubMed ID: 3939686
    [Abstract] [Full Text] [Related]

  • 18. Activation of murine CD8+ lymphocytes: two distinct signals regulate c-myc and interleukin 2 receptor RNA expression.
    Hardt C.
    Eur J Immunol; 1987 Dec 15; 17(12):1711-7. PubMed ID: 3121357
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-1 induces protein tyrosine phosphorylation in T cells.
    Muñoz E, Zubiaga A, Huang C, Huber BT.
    Eur J Immunol; 1992 Jun 15; 22(6):1391-6. PubMed ID: 1376256
    [Abstract] [Full Text] [Related]

  • 20. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J, Cusmano G, Introna M.
    J Immunol; 1992 Jul 01; 149(1):300-8. PubMed ID: 1376749
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.